Results 131 to 140 of about 819,937 (301)
Health Insurance as a Two-Part Pricing Contract [PDF]
Monopolies appear throughout health care markets, as a result of patents, limits to the extent of the market, or the presence of unique inputs and skills. In the health care industry, however, the deadweight costs of monopoly may be small or even absent.
Darius Lakdawalla, Neeraj Sood
core
Efficiencies of conventional anaerobic digestion procedure and ionizing radiation treatment for removal of pharmaceutical residues from municipal wastewater [PDF]
, 2016 Nowadays, pharmaceutical products (PPs) have raised global concerns due to accumulation of their residues in aquatic ecosystems. In the urban environment, epidemics and social factor illnesses, advancement of pharmaceutical industry, hospitals and other ...
Bartkevics, V. +4 more
core
Arthritis Care &Research, EarlyView.Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper +7 more
wiley +1 more source
Insurance and Incentives for Medical Innovation [PDF]
This paper studies the interactions between health insurance and the incentives for innovation. Although we focus on pharmaceutical innovation, our discussion applies to other industries producing novel technologies for sale in markets with subsidized ...
Alan M. Garber +2 more
core
American Journal of Pharmaceutical Education, 1994 Matthew M. Murawski +1 more
openaire +1 more source
Integrating community pharmacy and NHS Direct - pharmacists' views [PDF]
, 2002 AIM:To establish the views of community pharmacists on NHS Direct and its forthcoming integration with community pharmacy. DESIGN: Postal questionnaire survey. SUBJECTS AND SETTING: Pharmacists working in community pharmacies within the area of the
Knowles, E. +3 more
core
High Health Care Utilization Preceding Diagnosis With Juvenile Idiopathic Arthritis
Arthritis Care &Research, EarlyView.Objective Although early diagnosis improves long‐term outcomes, patients with juvenile idiopathic arthritis (JIA) often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize health care utilization in the year preceding diagnosis. Methods We identified 10,021 patients with an incident diagnosis
Anna Costello +5 more
wiley +1 more source
Associations of Rheumatoid Arthritis Disease Activity with Frailty Over Five Years of Follow‐up
Arthritis Care &Research, Accepted Article.Objective To evaluate whether rheumatoid arthritis (RA) disease activity is associated with frailty both in cross‐section and longitudinally. Methods Participants within the Veterans Affairs Rheumatoid Arthritis registry enrolled from 2003 to 2022 were included. The exposure was RA disease activity measured by Disease Activity Score in 28‐joints (DAS28)
Courtney N. Loecker +14 more
wiley +1 more source
Arthritis Care &Research, Accepted Article.Objectives Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), yet the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to: 1) identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Inconsistencias conceptuales relacionadas con la utilización de los RNM
Pharmaceutical Care España, 2016 Fundación Pharmaceutical Care España -
doaj +2 more sources